FranΓ§aisπ See the interactive version (live chart) β
For CRH plc, we replayed every analyst price target of the past 12 months and measured the real outcome: 62% were profitable, average return +21% (24 calls). At 3 months: +3% average return (48% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Truist Securities | 5 | 80% | +24% |
Is CRH plc overvalued, and is it a good time to buy CRH plc right now? If you're wondering, here's a recap to make up your own mind: CRH plc's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | CRH plc | Sector median (Materials) |
|---|---|---|
| P/E | 17.2 | 23.4 |
| Forward P/E | 14.5 | 15.9 |
| Net margin | 10% | 8% |
π CRH plc trades below its sector median (17.2 vs 23.4) β potentially undervalued, or lower expected growth.
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : CRH plc pays about $0.78/share/yr β 0.74% yield. what is this?
The analyst consensus on CRH plc (CRH) is "Buy" (21 bullish, 0 bearish calls over 12 months). This is not advice: historically, 62% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $137 (+43% vs $95.58), ranging from $125 to $166 (7 analysts).
Over 1 year, 62% of analyst targets on CRH plc were profitable, for an average return of +21% (across 24 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $137 within 12 months, i.e. +43% vs the current price. The most bullish targets $166, the most cautious $125.
Note: analyst targets are 12-month (median $137, +43%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (62%), and the stock's past trajectory.
Its P/E is 17.2, forward P/E 14.5. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of CRH plc β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.